Effects of superoxide dismutase mimetics on the activity of nitric oxide in rat aorta
Open Access
- 1 July 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (5) , 1159-1164
- https://doi.org/10.1038/sj.bjp.0702670
Abstract
A number of structurally distinct superoxide dismutase (SOD) mimetics were examined to determine if they shared the ability of authentic Cu/Zn SOD to produce endothelium‐dependent relaxation of rings of rat aorta by protecting basal nitric oxide from destruction by endogenously produced superoxide anion. MnCl2 (10 nM–100 μM), CuSO4 (100 nM–1 mM) and CuDIPS (Cu [II]‐[diisopropylsalicylate]2; 100 nM–30 μM) each mimicked the ability of Cu/Zn SOD (0.1–300 u ml−1) to produce relaxation of phenylephrine‐precontracted aortic rings in a manner inhibited by endothelial removal or treatment with NG‐nitro‐L‐arginine methyl ester (L‐NAME, 100 μM). In contrast, MnTMPyP (Mn [III] tetrakis [1‐methyl‐4‐pyridyl] porphyrin; 10 nM–30 μM) augmented phenylephrine‐induced contraction and this was blocked by endothelial removal or treatment with L‐NAME (100 μM), consistent with destruction rather than protection of basal nitric oxide activity. Pretreatment with Cu/Zn SOD (250 u ml−1) blocked this augmentation suggesting that it arose paradoxically through destruction of nitric oxide by superoxide anion. The spin trap agents tiron (100 nM–1 mM), tempol (100 nM–1 mM) and PTIYO (4‐phenyl‐2,2,5,5‐tetramethyl imidazolin‐1‐yloxy‐5‐oxide; 100 nM–300 μM) all failed to promote endothelium‐dependent relaxation. In fact, the last two augmented phenylephrine‐induced tone and this was blocked by endothelial removal or treatment with L‐NAME (100 μM), consistent with destruction of basal nitric oxide activity. This destruction was unaffected by pretreatment with Cu/Zn SOD (250 u ml−1) and probably reflected the direct ability of tempol and PTIYO to destroy nitric oxide. Thus, the ideal SOD mimetic for protection of nitric oxide activity in conditions of oxidant stress still awaits development. British Journal of Pharmacology (1999) 127, 1159–1164; doi:10.1038/sj.bjp.0702670Keywords
This publication has 32 references indexed in Scilit:
- Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic ringsBritish Journal of Pharmacology, 1999
- Normalization of Blood Pressure and Renal Vascular Resistance in SHR With a Membrane-Permeable Superoxide Dismutase MimeticHypertension, 1998
- Inhibition of nitrergic neurotransmission in the bovine retractor penis muscle by an oxidant stress: effects of superoxide dismutase mimeticsBritish Journal of Pharmacology, 1998
- Anatomic Heterogeneity of Vascular AgingHypertension, 1997
- NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of superoxide dismutase with diethyldithiocarbamateNeuropharmacology, 1994
- Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.bul.NO (nitric oxide) through a radical reactionBiochemistry, 1993
- Biologically active metal-independent superoxide dismutase mimicsBiochemistry, 1990
- Inactivation of intracellular copper-zinc superoxide dismutase by copper chelating agents without glutathione depletion and methemoglobin formationFree Radical Biology & Medicine, 1989
- Superoxide dismutase-like activities of copper(II) complexes tested in serumBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986